Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth

Cancer Science

Volumn 100, Issue 9, 2009, Pages 1648-1654

  Taniguchi, Koji ^a,b,c   Ishizaki, Takuma ^c   Ayada, Toranoshin ^a   Sugiyama, Yuki ^c   Wakabayashi, Yu ^c   Sekiya, Takashi ^c   Nakagawa, Ryusuke ^c   Yoshimura, Akihiko ^c,d  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; FIBROBLAST GROWTH FACTOR 2; LUCIFERASE; LYSOPHOSPHOLIPID; NERVE PROTEIN; RAS PROTEIN; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1-PHOSPHATE; SPRY4 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL; ANIMAL EMBRYO; ARTICLE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG SCREENING; EXPERIMENTAL MELANOMA; FIBROBLAST; LEWIS CARCINOMA; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; THORACIC AORTA; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CELLS, CULTURED; EMBRYO, MAMMALIAN; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; LUCIFERASES; LYSOPHOSPHOLIPIDS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; RAS PROTEINS; SPHINGOSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70149089678     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01214.x     Document Type: Article

References (30)

1. Kim HJ, Bar-Sagi D. Modulation of signalling by Sprouty: a developing story. Nat Rev Mol Cell Biol 2004; 5: 441-50.
2. Mason JM, Morrison DJ, Basson MA, Licht JD. Sprouty proteins:multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 2006; 16: 45-54.
3. Cabrita MA, Christofori G. Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 2008; 11: 53-62.
4. Wakioka T, Sasaki A, Kato R et al. Spred is a Sprouty-related suppressor of Ras signalling. Nature 2001; 412: 647-51.
5. Kato R, Nonami A, Taketomi T et al. Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation. Biochem Biophys Res Commun 2003; 302: 767-72.
6. Sasaki A, Taketomi T, Wakioka T, Kato R, Yoshimura A. Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem 2001; 276: 36804-8.
7. Sasaki A, Taketomi T, Kato R et al. Mammalian Sprouty4 suppresses Rasindependent ERK activation by binding to Raf1. Nat Cell Biol 2003; 5: 427-32.
8. Taniguchi K, Kohno R, Ayada T et al. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol Cell Biol 2007; 27: 4541-50.
9. Gross I, Bassit B, Benezra M, Licht JD. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem 2001; 276: 46460-8.
10. Hanafusa H, Torii S, Yasunaga T, Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 2002; 4: 850-8.
11. Yusoff P, Lao DH, Ong SH et al. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 2002; 277: 3195-201.
12. Ayada T, Taniguchi K, Okamoto F et al. Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis. Oncogene 2009; 28: 1076-88.
13. Lo TL, Fong CW, Yusoff P et al. Sprouty and cancer: the first terms report.Cancer Lett 2006; 242: 141-50.
14. Yoshida T, Hisamoto T, Akiba J et al. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene 2006; 25: 6056-66.
15. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002; 2: 795-803.
16. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48-50.
17. Shibuya M. Vascular endothelial growth factor-dependent and - independent regulation of angiogenesis. BMB Rep 2008; 41: 278-86.
18. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9: 139-50.
19. Taniguchi K, Ayada T, Ichiyama K et al. Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling.Biochem Biophys Res Commun 2007; 352: 896-902.
20. Nishinakamura H, Minoda Y, Saeki K et al. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity. Int Immunol 2007; 19: 609-19.
21. Hamada K, Sasaki T, Koni PA et al. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 2005; 19:2054-65.
22. Tammela T, Zarkada G, Wallgard E et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008; 454:656-60.
23. Mamluk R, Klagsbrun M, Detmar M, Bielenberg DR. Soluble neuropilin targeted to the skin inhibits vascular permeability. Angiogenesis 2005; 8:217-27.
24. Reynolds LE, Wyder L, Lively JC et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nature Med 2002; 8: 27-34.
25. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors.Nat Med 2003; 9: 669-76.
26. Takahashi T, Yamaguchi S, Chida K, Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.EMBO J 2001; 20: 2768-78.
27. Wong C, Jin ZG. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J Biol Chem 2005; 280: 33262-9.
28. Qin L, Zeng H, Zhao D. Requirement of protein kinase D tyrosine phosphorylation for VEGF-A165-induced angiogenesis through its interaction and regulation of phospholipase Cgamma phosphorylation. J Biol Chem 2006; 281: 32550-8.
29. Brems H, Chmara M, Sahbatou M et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007; 39:1120-6.
30. Sivak JM, Petersen LF, Amaya E. FGF signal interpretation is directed by Sprouty and Spred proteins during mesoderm formation. Dev Cell 2005; 8:689-701.